Revolutionary Obesity Treatment: Tirzepatide Shows Groundbreaking 21.1% Weight Loss

A phase 3 clinical trial has found that the injectable prescription medication tirzepatide, in combination with intensive lifestyle intervention, resulted in an additional 21.1% weight…